HOME >> BIOLOGY >> NEWS
AHA Issues Scientific Statement On Infective Endocarditis

American Heart Association Journal Report:

DALLAS, Dec. 22 -- The American Heart Association today issues a new scientific statement that updates the procedures for diagnosing and treating infective endocarditis, a life-threatening heart infection that can be caused by common microbes such as streptococcus or "strep."

The statement by the AHA's Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease is published in today's Circulation: Journal of the American Heart Association.

Infective endocarditis (IE) occurs when bacteria or fungus cause severe infections in the inner lining of the heart or heart valves, leading to tissue damage or destruction. Antibiotics can usually treat the bacterial infections, but if the disease is not detected, the infection can gradually destroy the heart lining or heart valves. Also, clumps of the bacteria can break off and travel through the blood vessels to other organs, including the brain. This can cause serious injury to these organs or even death.

About 20,000-30,000 people develop IE, a disease that represents the fourth leading cause of life-threatening infections such as pneumonia, according to Kathryn A. Taubert, Ph.D., senior scientist in the AHA's department of science and medicine and a co-author of the statement.

Individuals at risk for IE include people with certain defects of the heart present at birth, heart valve disorders, mitral valve prolapse, a history of rheumatic heart disease, or anyone who has an artificial heart valve.

Individuals who are intravenous drug abusers are also at high risk for IE. The statement is the first from the American Heart Association to recommend the set of diagnostic criteria for IE developed by researchers at Duke University Medical Center. The previous diagnostic criteria relied on tests that measured bacteremia (high amounts of bacteria in the blood), regurgitant murmur (a heart abnormality) and blood vessel complications. The ne
'"/>

Contact: Brian Henry
brianh@heart.org
214-706-1135
American Heart Association
21-Dec-1998


Page: 1 2

Related biology news :

1. Immigration and Travel Issues for Foreign Scientists and Technology Workers
2. Trade, science, risk, precaution: Issues for Seattle
3. Researchers, Regulators, Industry, Consumer Advocates Gather to Discuss Critical Issues Facing the Pharmaceutical Industry
4. USGS Issues Wildlife Health Alert: Associates Virus With Salamander Die-Offs
5. "Health Of Hanford" Conference Gathers Diverse Audience To Review And Discuss Health Issues
6. China And USGS--Working Together On Environmental Issues
7. Antimicrobial Resistance: Issues And Options
8. American Museum Of Natural History Holds Symposium On Biodiversity And Human Health Issues
9. 2nd media alert First Scientific Conference on Childhood Leukaemia
10. First International Scientific Conference on Childhood Leukaemia
11. Scientific publications: Time for change

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... June 23, 2020 , ... Rigaku ... the next event in a series of TOPIQ webinars, which will cover the ... webinars was developed in response to social distancing measures that resulted in postponements ...
(Date:6/19/2020)... BOSTON (PRWEB) , ... June 16, 2020 , ... The ... Ph.D., is betting that if the stem cell medicine and pharmaceutical industries have easier ... their practice. So, starting July 5 of this year, Independence Day weekend in ...
(Date:6/19/2020)... ... June 18, 2020 , ... Join experts from ... Principal Scientist in a live webinar on Wednesday, July 8, 2020 at ... the way we genetically engineer new models. However, while modifying the genome may be ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... ... June 22, 2020 , ... Dracen Pharmaceuticals Inc., ... presented June 22-24 during the American Association for Cancer Research Virtual meeting. One ... the potent, consistent single agent activity in KEAP1 mutant tumor models of NSCLC. ...
(Date:6/11/2020)... ... June 08, 2020 , ... ... platform delivered through the use of proprietary clean viral vectors, recently announced a ... United States. Greffex’s platform is the world’s most successful gene therapy delivery ...
(Date:6/11/2020)... (PRWEB) , ... June 09, 2020 , ... Reducing carbon ... the world. From the Paris Agreement to stock market dips, ways to reduce CO2 ... adding biofuels to their portfolio. Most of the biofuels being produced today are created ...
(Date:5/30/2020)... ... May 29, 2020 , ... ... diagnostics, and animal health markets, has enabled Cytovale, Inc., a medical technology company ... machine learning, to achieve their first patient in (FPI) in just seven days. ...
Breaking Biology Technology:
Cached News: